NASDAQ$BTTC

Black Titan Corp · Q3 2013 earnings

Q3 2013 earnings · · Investor relations

Headline financials

Total Revenue

-$120K

Previous: $1.23M-109.8%
EPS (adj)

-$0.60

Previous: -$3.60+83.3%
Capital Expenditures

-$1K

Previous: $133K-100.8%
Free Cash Flow

-$2.18M

Previous: -$2.51M+13.2%
Net Income

$131K

Previous: -$8.01M+101.6%
Operating Income

$142K

Previous: -$2.66M+105.3%
Gross Profit

$599K

Previous: -$1.77M+133.9%
Cash & Equivalents

$570K

Previous: $5.06M-88.7%
Total Assets

$8.1M

Previous: $10.7M-24.6%
Stock-Based Comp

$21K

Previous: $365K-94.2%

Revenue & EPS history

Titan Pharmaceuticals · Revenue · Quarterly

-$120K

Q3 2013-109.8%vs Q3 2012
Beat estimate in 2 of 2 quarters(100%)
ActualEstimate

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro